US 9669095
Cyclosporin analogues for preventing or treating hepatitis C infection
granted A61KA61K31/7056A61K38/13
Quick answer
US patent 9669095 (Cyclosporin analogues for preventing or treating hepatitis C infection) held by Enanta Pharmaceuticals, Inc. expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/7056, A61K38/13, A61K38/21, A61K45/06